MD, PhD and Chief Technology Officer of BioViva Science
Dr Avi Roy, is an Oxford-based biomedical scientist, with degrees in biomedical science and computer science. He is a Research Fellow at the Institute for Translational Medicine at the University of Buckingham (BITM). Additionally, Avi advises academia, biotech, governments, and pharma startups, including University of Oxford’s Centre for Advancing Sustainable Medical Innovation (CASMI), University of Oxford’s Future of Humanity Institute, Thiel Capital, New Medicine Partners, Deep Knowledge Ventures, and Government of Kazakhstan. Avi’s PhD research involved the rejuvenation of human skin using small molecules and identifying accurate biomarkers of ageing. Avi rejuvenated the skin cells taken from 80-year-old patients by transplanting the mitochondria taken from 16-year-old skin cells.
Over the past decade, Avi has headed the Oxford University Scientific Society, the world’s oldest student scientific organisation. He also co-founded the Oxford Transhumanism and Emerging Technology Society, and the Oxford University Synthetic Biology Society.
Recently, Avi has launched the Big Data Science in Medicine Conference series and the Longevity Reporter, which is a source for news about health and longevity.